ILMN Share Price

Open 123.80 Change Price %
High 124.49 1 Day -4.39 -3.47
Low 119.37 1 Week -5.71 -4.47
Close 122.01 1 Month -15.69 -11.39
Volume 2504929 1 Year -59.73 -32.87
52 Week High 196.47
52 Week Low 119.37
ILMN Important Levels
Resistance 2 126.76
Resistance 1 124.80
Pivot 121.96
Support 1 119.22
Support 2 117.26
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.45 7.29%
MU 20.45 7.29%
MU 20.45 7.29%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ANTH 2.03 38.10%
EMKR 8.45 31.01%
MBLX 0.32 28.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
HTCO 8.00 23.08%
ATEA 1.95 21.88%
ATEA 1.95 21.88%
More..
NASDAQ USA Top Losers Stocks
DSTI 0.00 -100.00%
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Illumina, Inc. (NASDAQ: ILMN)

ILMN Technical Analysis 5
As on 7th Dec 2016 ILMN Share Price closed @ 122.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 152.98 & Strong Sell for SHORT-TERM with Stoploss of 147.70 we also expect STOCK to react on Following IMPORTANT LEVELS.
ILMN Target for December
1st Target up-side 142.09
2nd Target up-side 148.37
3rd Target up-side 154.65
1st Target down-side 124.19
2nd Target down-side 117.91
3rd Target down-side 111.63
ILMN Other Details
Segment EQ
Market Capital 5882942464.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.illumina.com
ILMN Address
ILMN
5200 Illumina Way
San Diego, CA 92122
United States
Phone: 858-202-4500
Fax: 858-202-4766
Interactive Technical Analysis Chart Illumina, Inc. ( ILMN NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Illumina, Inc.
ILMN Business Profile
Illumina, Inc. (Illumina) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. The Company provides a line of genetic analysis solutions, with products and services that serve a range of interconnected markets, including sequencing, genotyping, gene expression, and molecular diagnostics. The Company is organized in two business segments: Life Sciences and Diagnostics. Its Life Sciences business unit includes all products and services related to the research market, namely the product lines based on its sequencing, BeadArray, VeraCode, and real-time PCR technologies. Its Diagnostics business unit focuses on molecular diagnostics. In February 2014, Illumina, Inc. announced that Novogene purchased one HiSeq X Ten.